Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2012-05-11

FDA Approved: TAZAROTENE — Original Application (Mayne Pharma Inc.)

View source ↗

Summary

The FDA approved Mayne Pharma's original application for tazarotene, a topical retinoid, for dermatologic use.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • TAZAROTENE (TAZAROTENE)

Snippet

ORIG AP for TAZAROTENE (TAZAROTENE)